·
15 MIN READ

AMA president assesses nation’s health care system

Reflects on AMA leadership in rebuilding broken health care system.

Press Releases
UPDATED
·
2 MIN READ

AMA advocacy efforts: Public health

The AMA advocates at the federal and state levels on key issues in public health.

Patient Support & Advocacy
AMA in Action: Ending the overdose epidemic
UPDATED
·
5 MIN READ

Advocacy in action: Ending the overdose epidemic

Science, evidence and compassion must guide patient care and policy change to end the drug-overdose epidemic.

Overdose Epidemic
·
10 MIN READ

May 19, 2023: National Advocacy Update

 Senate Committee passes bipartisan PBM legislation and more in the latest National Advocacy Update.

Advocacy Update
Narcan nasal spray
·
4 MIN READ

Narcan lands OTC approval: What it means for patients, doctors

The drug’s manufacturer and retailers must help ensure the lifesaving opioid overdose-reversal medication is widely available at an affordable price. 

Overdose Epidemic
·
12 MIN READ

Naloxone: FDA approves over-the-counter Narcan nasal spray with Bobby Mukkamala, MD

The AMA Update covers a range of health care topics affecting the lives of physicians and patients. Learn more about Narcan, the over-the-counter naloxone nasal spray, and more.

series
Overdose Epidemic
AMA Update
·
12 MIN READ

Naloxone: FDA approves over-the-counter Narcan nasal spray with Bobby Mukkamala, MD [Podcast]

The AMA Update covers a range of health care topics affecting the lives of physicians and patients. Learn more about Narcan, the over-the-counter naloxone nasal spray, and more.

series
Overdose Epidemic
AMA Update Podcast
·
12 MIN READ

April 7, 2023: National Advocacy Update

Long-sought Medicare payment proposal introduced and more in the latest National Advocacy Update.

Advocacy Update
·
4 MIN READ

Top news stories from AMA Morning Rounds®: Week of March 27, 2023

In the news: FDA rule on salt substitutes, undiagnosed atrial fibrillation in the U.S., Narcan (naloxone) to be available over the counter and more.

Publications & Newsletters